TRIM67 Promotes Non-Small Cell Lung Cancer Development by Positively Regulating the Notch Pathway through DLK1 Ubiquitination
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tripartite motif-containing 67 (TRIM67) promotes non-small cell lung cancer (NSCLC) growth by activating the Notch pathway. TRIM67 ubiquitinates DLK1, enhancing cancer cell invasion, migration, and proliferation, indicating a potential therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Tripartite motif-containing 67 (TRIM67) is an E3 ubiquitin ligase implicated in carcinogenesis.
- Previous studies linked TRIM67 expression to advanced tumor stages, metastasis, and poor prognosis in various cancers.
- TRIM67 has been shown to activate the Notch pathway, promoting cancer cell aggressiveness.
Purpose Of The Study
- To elucidate the specific mechanism by which TRIM67 influences the Notch pathway in non-small cell lung cancer (NSCLC).
- To investigate the role of TRIM67 in regulating DLK1 and its subsequent impact on NSCLC cell behavior.
Main Methods
- Immunohistochemistry to assess TRIM67 expression and its correlation with clinicopathological features.
- Western blotting and ubiquitination assays to determine TRIM67's effect on DLK1.
- Cellular assays (invasion, migration, proliferation) to evaluate the functional consequences of TRIM67-DLK1 interaction.
Main Results
- TRIM67 expression correlates with poor prognostic indicators in NSCLC, including p-TNM stage and lymph node metastasis.
- TRIM67 directly ubiquitinates atypical ligand delta like non-canonical Notch ligand 1 (DLK1) via its RING domain.
- This ubiquitination event by TRIM67 leads to the activation of the Notch pathway, promoting NSCLC cell invasion, migration, and proliferation.
Conclusions
- TRIM67 promotes NSCLC progression by ubiquitinating DLK1 and activating the Notch signaling pathway.
- TRIM67 represents a potential therapeutic target for managing NSCLC.
- Targeting the TRIM67-DLK1-Notch axis may offer a novel strategy for NSCLC treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...